[Federal Register Volume 70, Number 203 (Friday, October 21, 2005)]
[Notices]
[Page 61293]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-21036]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Board to the Food and Drug Administration; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Science Board to FDA.
    General Function of the Committee: The Board shall provide advice 
primarily to the agency's Senior Science Advisor and, as needed, to the 
Commissioner of Food and Drugs and other appropriate officials on 
specific complex and technical issues as well as emerging issues within 
the scientific community in industry and academia. Additionally, the 
Board will provide advice to the agency on keeping pace with technical 
and scientific evolutions in the fields of regulatory science, on 
formulating an appropriate research agenda, and on upgrading its 
scientific and research facilities to keep pace with these changes. It 
will also provide the means for critical review of agency-sponsored 
intramural and extramural scientific research programs.
    Date and Time: The meeting will be held on November 4, 2005, from 
8:30 a.m. to 4 p.m.
    Location: Washington Room, Holiday Inn Bethesda, 8120 Wisconsin 
Ave., Bethesda, MD.
    Contact Person: Jan Johannessen, Office of the Commissioner (HF-
33), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-827-6687, [email protected], or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 3014512603. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The Science Board will hear about and discuss the following 
topics: (1) An update on activities of the Drug Safety Oversight Board, 
(2) the agency's Bioresearch Monitoring Initiative, and (3) the Board's 
science peer review activities, including presentation of the Board's 
peer review of the Office of Regulatory Affairs' pesticide monitoring 
program.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by October 28, 
2005. Oral presentations from the public will be scheduled between 
approximately 12:30 p.m. and 1:30 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before October 28, 2005, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jan Johannessen at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 14, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-21036 Filed 10-20-05; 8:45 am]
BILLING CODE 4160-01-S